Rigontec
2014
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
$551M
LATEST DEAL AMOUNT
Description
Developer of RNA-based immunotherapeutics for cancer and viral diseases intended to harness one of the most essential pathways in the innate immune system. The company's RNA-based immunotherapeutics offers proprietary retinoic acid inducible gene I (RIG-I) activators for the treatment of cancer and is designed to initiate specific activation of multiple RIG-I pathways to kill tumor cells and to enable long-term immunity against the cancer associated with the tumor, enabling healthcare providers to generate effective therapies.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Office
- Izb, Am Klopferspitz 19
- Planegg/Martinsried
- 82152 Munich
- Germany
+49 089 000000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Rigontec’s full profile, request a free trial.
Rigontec Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 26-Oct-2017 | $551M | 000.00 | 00000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A) | 06-Sep-2016 | 000.00 | 000.00 | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Rigontec Competitors (38)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gadeta | Venture Capital-Backed | Utrecht, Netherlands | 00.000 | 00000000000 | 00.000 | |
| 000000000 | Venture Capital-Backed | Rockville, MD | 000.00 | 0000000000 0 | 000.00 | |
| 000000000000 | Venture Capital-Backed | Houston, TX | 000.00 | 00000000000 | 000.00 | |
| 00000000 | Venture Capital-Backed | Tübingen, Germany | 000 | 00000 | 00000000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Watertown, MA | 00 | 00000 | 000000000 | 00000 |
Rigontec Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Venture Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Forbion | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| German Accelerator | Accelerator/Incubator | 000 0000 | 000000 0 | |||
| High-Tech Gründerfonds | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| MP Healthcare Venture Management | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
Rigontec Executive Team (10)
1 Former Executive
You’re viewing 5 of 10 executives. Get the full list »Rigontec Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Christian Schetter Ph.D | Rigontec | Chief Executive Officer & Board Member | 000 0000 | |
| Donald DeBethizy Ph.D | Rigontec | Chairman | 000 0000 | |
| Gunther Hartmann | Self | Advisor, Board Member & Co-Founder | 000 0000 |
4 Former Board Members
You’re viewing 3 of 7 board members. Get the full list »